JGH offers global credit exposure and a high 9.8% yield, but struggles in the current high interest rate environment. The fund's heavy allocation to below-investment-grade debt and use of leverage ...

Buffalo, New York--(Newsfile Corp. - November 21, 2022) - GVB Biopharma, a 22nd Century Group company (NASDAQ: XXII), today announced that a fire occurred at its GVB Biopharma distillate and ...

The governor’s visit to GVB comes after the release of an initial draft of a tourism situation report prepared by private sector tourism executives, pointing to Guam’s tourism industry as ...

GVB Biopharma has Achieved Strong Growth and Leading Market Share in Hemp-Derived Active Ingredients BUFFALO, N.Y., May 13, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a ...